Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations (Q28743688)
Jump to navigation
Jump to search
scientific article (publication date: 2011)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations |
scientific article (publication date: 2011) |
Statements
Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations (English)
0 references
2011
0 references
6
0 references
6
0 references
e20733
0 references
13 June 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference